U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Name Type Language
RAVAGALIMAB
INN  
Official Name English
ravagalimab [INN]
Common Name English
IMMUNOGLOBULIN G1, (ANTI-HUMAN CD19 (ANTIGEN)) (HUMANIZED CLONE RB4V1.2 .GAMMA.1-CHAIN), DISULFIDE WITH HUMANIZED CLONE RB4V1.2 .KAPPA.-CHAIN, DIMER
Systematic Name English
ABBV-323
Code English
RAVAGALIMAB [USAN]
Common Name English
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 5 (B-CELL SURFACE ANTIGEN CD40))HUMANIZED MONOCLONAL ANTIBODY.GAMMA.1 HEAVY CHAIN (1-446) (HUMANIZED VH (HOMO SAPIENS IGHV3-48*01 (90%) (IGHD)-IGHJ6*01) (8.8.9)
Systematic Name English
PR-1629977
Code English
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD40 ANTIGEN) (HUMANIZED MOUSE MONOCLONAL PR-1629977 .GAMMA.1-CHAIN), DISULFIDE WITH HUMANIZED MOUSE MONOCLONAL PR-1629977 .KAPPA.-CHAIN, DIMER
Common Name English
Code System Code Type Description
NCI_THESAURUS
C170363
Created by admin on Sat Dec 16 14:38:21 GMT 2023 , Edited by admin on Sat Dec 16 14:38:21 GMT 2023
PRIMARY
INN
10750
Created by admin on Sat Dec 16 14:38:21 GMT 2023 , Edited by admin on Sat Dec 16 14:38:21 GMT 2023
PRIMARY
USAN
GH-77
Created by admin on Sat Dec 16 14:38:21 GMT 2023 , Edited by admin on Sat Dec 16 14:38:21 GMT 2023
PRIMARY
CAS
2050816-56-1
Created by admin on Sat Dec 16 14:38:21 GMT 2023 , Edited by admin on Sat Dec 16 14:38:21 GMT 2023
PRIMARY
FDA UNII
YGF9TW3QZJ
Created by admin on Sat Dec 16 14:38:21 GMT 2023 , Edited by admin on Sat Dec 16 14:38:21 GMT 2023
PRIMARY
ACTIVE MOIETY
RAVAGALIMAB
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966